ProCE Banner Activity

COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments

Slideset Download
Downloadable slideset including the latest data on the use of monoclonal antibodies for the treatment and prophylaxis of COVID-19.

Released: April 15, 2022

Expiration: April 14, 2023

No longer available for credit.

Share

Faculty

Gregory Huhn

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Gregory Huhn, MD, MPHTM, has disclosed that he has received funds for research support from Lilly and consulting fees from Gilead Sciences, Janssen, and ViiV.